Comparison of two immunoassays for the measurement of serum HE4 for ovarian cancer

INTRODUCTION: The use of Human Epididymis Protein 4 (HE4) as a biomarker for ovarian cancer is gaining traction, providing the impetus for development of a high throughput automated HE4 assay that is comparable to the conventional manual enzyme immunometric-assay (EIA). The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Barr, Chloe E., Funston, Garth, Mounce, Luke T.A., Pemberton, Phillip W., Howe, Jonathon D., Crosbie, Emma J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138765/
https://www.ncbi.nlm.nih.gov/pubmed/34036134
http://dx.doi.org/10.1016/j.plabm.2021.e00235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138765/
https://www.ncbi.nlm.nih.gov/pubmed/34036134
http://dx.doi.org/10.1016/j.plabm.2021.e00235

Ejemplares similares